NPB vs ZTS · P/E 7.5, rev $380.2M vs P/E 25, rev $2.47B
Northpointe Bancshares, Inc. (NPB) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Northpointe Bancshares, Inc. (NPB) is a banks - regional company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported NPB revenue for 2025-12-31 was $380.2M. Net income was $83.4M. Revenue was up 19.7% from 2024-12-31 to 2025-12-31. NPB currently screens at market cap $582.7M and trailing P/E 7.5.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
NPB currently screens at market cap $582.7M and trailing P/E 7.5. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the NPB and ZTS stock pages for the full models.
Not investment advice.